HealthcareServices

Genomic Biomarkers Market Research: Growth Projections and Trends 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the genomic biomarkers market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Genomic Biomarkers Market size between 2026 and 2035?

The genomic biomarkers market has experienced rapid expansion in recent years. This market is projected to expand from $8.72 billion in 2025 to $10.24 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.5%. The historical growth of this market is attributable to key factors such as advancements in genomic sequencing technologies, the expansion of biomarker research focused on oncology, increased adoption of personalized treatment approaches, enhancements in clinical validation frameworks, and the growing availability of genomic databases.

The genomic biomarkers market is projected to experience substantial expansion, reaching $19.33 billion by 2030, with a compound annual growth rate (CAGR) of 17.2%. This anticipated growth is driven by factors such as increased funding for precision medicine initiatives, a greater need for tools that enable early disease detection, the broadening scope of biomarker-guided drug development, the escalating incorporation of AI into biomarker analysis, and strengthened regulatory backing for personalized treatments. Key trends expected during this period involve the rising uptake of precision medicine guided by biomarkers, the increasing incorporation of genomic data into clinical decision-making processes, an expanding reliance on companion diagnostics, the development of more extensive multi-omics biomarker platforms, and a heightened emphasis on clinical validation criteria.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19485&type=smp

Which Drivers Are Impacting Market Performance In The Genomic Biomarkers Market?

The rising need for personalized medicine is projected to fuel the expansion of the genomic biomarkers market in the foreseeable future. This medical strategy, often termed precision medicine, customizes healthcare choices and therapies for each patient’s unique attributes, mainly utilizing their genetic and genomic data. This surge in demand stems from various elements, including a heightened focus on patient-centric care, breakthroughs in genetic sequencing and analysis, a patient-focused methodology, and the utilization of EHRs for data storage and examination. Genomic biomarkers are vital in personalized medicine, empowering medical professionals to customize treatments according to an individual’s distinct genetic profile. This method, also referred to as precision medicine, seeks to enhance treatment efficacy and lessen adverse reactions by accounting for genetic variations among individuals. As an illustration, in February 2024, the Personalized Medicine Coalition, a US-based professional membership organization, reported that in 2023, the FDA sanctioned 16 novel personalized therapies for rare disease patients, an increase from six in 2022. Consequently, the escalating demand for personalized medicine acts as a key driver for the genomic biomarkers market’s growth.

Which Segments Are Contributing To The Growth Of The Genomic Biomarkers Market?

The genomic biomarkers market covered in this report is segmented –

1) By Type: Predictive Biomarkers, Prognostic Biomarkers

2) By Disease Indication: Oncology, Cardiovascular Diseases, Neurological Diseases, Renal Disorders, Other Disease Indications

3) By Validation: Analytical Validation, Clinical Validation, Clinical Utility

4) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By Predictive Biomarkers: Drug Response Biomarkers, Companion Diagnostics Biomarkers, Pharmacodynamic Biomarkers, Predictive Genetic Markers for Disease Susceptibility

2) By Prognostic Biomarkers: Cancer Prognostic Biomarkers, Cardiovascular Disease Prognostic Biomarkers, Neurodegenerative Disease Prognostic Biomarkers, Infectious Disease Prognostic Biomarkers

Which Trends Are Influencing The Performance And Direction Of The Genomic Biomarkers Market?

Major companies within the genomic biomarkers market are focused on creating innovative products, such as lung reagents, to improve the detection of specific genetic mutations in lung cancer, enhance diagnostic accuracy, and facilitate personalized treatment approaches through advanced genomic technologies. Lung reagents are specialized chemical or biological substances employed in diagnostic tests, research, or medical procedures related to the lungs, supporting precision medicine by guiding treatment selections based on the cancer’s unique genetic profile. For instance, in December 2023, Biofidelity, a UK-based company specializing in developing advanced genomic assays and precision diagnostics, released ASPYRE-Lung reagents. The ASPYRE-Lung reagents are designed to pinpoint key genetic mutations and alterations in lung cancer, which are crucial for directing targeted therapies and personalized treatment strategies.

Who Are The Core Companies Influencing Trends In The Genomic Biomarkers Market?

Major companies operating in the genomic biomarkers market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd., Illumina Inc., PerkinElmer Inc., Almac Group, Azenta Inc., Novogene Corporation, Oxford Nanopore Technologies Ltd., Celerion, Quanterix Corporation, Bio-Rad Laboratories Inc., NantHealth Inc., Centogene N.V., Sophia Genetics SA, Envisagenics, Deep Genomics, Creative Diagnostics, Macrogen Inc., Guardant Health Inc., Sema4

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/genomic-biomarkers-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Genomic Biomarkers Market?

North America was the largest region in the genomic biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genomic biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Genomic Biomarkers Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19485&type=smp

Browse Through More Reports Similar to the Global Genomic Biomarkers Market 2026, By The Business Research Company

Digital Genome Market Report 2026

https://www.thebusinessresearchcompany.com/report/digital-genome-global-market-report

Single Cell Genome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

Whole Genome And Exome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795